Whitefort Capital Management, LP Arbutus Biopharma Corp Transaction History
Whitefort Capital Management, LP
- $170 Million
- Q1 2025
A detailed history of Whitefort Capital Management, LP transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Whitefort Capital Management, LP holds 13,307,967 shares of ABUS stock, worth $42.6 Million. This represents 27.3% of its overall portfolio holdings.
Number of Shares
13,307,967
Previous 13,241,916
0.5%
Holding current value
$42.6 Million
Previous $43.3 Million
7.26%
% of portfolio
27.3%
Previous 22.74%
Shares
9 transactions
Others Institutions Holding ABUS
# of Institutions
191Shares Held
111MCall Options Held
866KPut Options Held
608K-
Morgan Stanley New York, NY23.8MShares$76.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$37 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.47MShares$30.3 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.95MShares$28.7 Million0.0% of portfolio
-
State Street Corp Boston, MA4.36MShares$14 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $480M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...